/PRNewswire/ Sumitomo Pharma America, Inc. (SMPA), today announced the expansion of its partnership with actress and overactive bladder (OAB) patient Holly.
Urovant Sciences, Inc and Thinx, Inc Form a Unique Partnership Designed to Educate People Living with The Symptoms of Overactive Bladder (OAB) For Patients With OAB, Traveling or Enjoying